IV期无驱动基因改变的非小细胞肺癌治疗:ASCO动态指南2024.3版
该动态指南由ASCO专家小组定期系统检索文献更新,针对IV期无驱动基因改变的非小细胞肺癌的治疗提供推荐。指南强调不能替代临床医生的独立专业判断,且未考虑患者个体差异。
要点
- ASCO动态指南针对IV期无驱动基因改变的非小细胞肺癌的治疗。
- 由常设专家小组定期系统检索文献并更新推荐。
- 指南不替代临床医生的独立专业判断,未考虑患者个体差异。
核心结论
- 该动态指南针对IV期无驱动基因改变的非小细胞肺癌的治疗提供推荐,由ASCO常设专家小组定期系统更新。
研究设计与样本
- ASCO动态指南由常设专家小组按照ASCO指南方法学手册定期系统检索并审查健康文献进行更新。
临床怎么用
- 原文未据此给出推荐,仅说明动态指南不替代临床医生的独立专业判断且未考虑患者个体差异。
局限性
- 动态指南不替代临床医生的独立专业判断,且未考虑患者个体差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Living guidelines are developed for selected topic areas with rapidly evolving evidence that drives frequent change in recommended clinical practice. Living guidelines are updated on a regular schedule by a standing expert panel that systematically reviews the health literature on a continuous basis, as described in the ASCO Guidelines Methodology Manual. ASCO Living Guidelines follow the ASCO Conflict of Interest Policy Implementation for Clinical Practice Guidelines. Living Guidelines and updates are not intended to substitute for independent professional judgment of the treating clinician and do not account for individual variation among patients. See appendix for disclaimers and other important information (Appendix 1 and 2). Updates are published regularly and can be found at https://ascopubs.org/nsclc-non-da-living-guideline.
引用
- Leighl NB, Ismaila N, Durm G, et al. Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2024.3. J Clin Oncol. 2025. PMID: 40014838. doi:10.1200/JCO-24-02786
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。